A 14-day-old male infant is brought to the pediatrician by his mother due to a 3-day history of bilateral eye redness and discharge. The infant was born at 39 weeks gestation via an unassisted home birth to a 22-year-old mother who received no prenatal care. Postnatal care was limited, and the infant did not receive prophylactic eye drops at birth. The infant is breastfeeding well, produces 6 to 8 wet diapers daily, and has no fever or cough. Vital signs are within normal limits for his age. Physical examination shows bilateral eyelid edema, marked conjunctival injection, and moderate mucopurulent discharge. The remainder of the physical examination is unremarkable. Which of the following is the most appropriate next step in management?
- AApplication of topical erythromycin ophthalmic ointment
- BAdministration of intramuscular ceftriaxone
- CObservation and nasolacrimal duct massage
- Administration of oral azithromycinAnswer
- EAdministration of intravenous acyclovir
Answer
Administration of oral azithromycin is the most appropriate next step because the infant has classic signs of chlamydial conjunctivitis, which requires systemic macrolide therapy.
The patient has a classic presentation of inclusion conjunctivitis caused by *Chlamydia trachomatis*. Due to the lack of prenatal care, the mother's infectious status was unknown, placing the infant at high risk for vertical transmission during delivery. The onset of symptoms at 5 to 14 days of life, characterized by eyelid edema, marked conjunctival injection, and mucopurulent discharge, is highly specific for a chlamydial etiology. The standard of care is systemic treatment with an oral macrolide, such as azithromycin. Systemic treatment is essential because topical antibiotics do not eradicate the bacteria from the nasopharynx, which leaves the infant at significant risk for developing chlamydial pneumonia.
| Etiology | Onset | Clinical Presentation | Treatment |
|---|---|---|---|
| Chemical | < 24 hours | Mild conjunctival irritation and tearing | Observation |
| Gonococcal | 2-5 days | Hyperacute, severe purulent discharge, eyelid edema | Intramuscular ceftriaxone |
| Chlamydial | 5-14 days | Mild to severe mucopurulent discharge, watery initially | Oral macrolide (e.g., azithromycin) |
Step-by-Step Solution
Key Concept
Neonatal chlamydial conjunctivitis presents at 5-14 days of life and must be treated with an oral macrolide (e.g., azithromycin) to eradicate nasopharyngeal carriage and prevent chlamydial pneumonia.
Estimated Time:1m 0s